Stryker to Invest $400M in CMR Surgical, Gains U.S. Sales Rights and Acquisition Option

Insider Brief Stryker plans to invest approximately $400 million in British surgical robotics company CMR Surgical as part of a strategic alliance that gives the medical technology company exclusive U.S. sales rights to CMR’s Versius robotic surgery systems and an option to acquire the company.